Open AccessNevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women
Author(s) -
Betty J. Dong,
Yu Zheng,
Michael D. Hughes,
Adam Frymoyer,
Davide Verotta,
Patricia Lizak,
Frederick Sawe,
Judith S. Currier,
Shahin Lockman,
Francesca Aweeka
Publication year - 2012
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e328351a521
Subject(s) - nevirapine , rash , medicine , pharmacokinetics , population , regimen , gastroenterology , pharmacology , immunology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , environmental health
To estimate nevirapine (NVP) pharmacokinetics and examine its association with rash and/or hepatotoxicity in women starting antiretroviral treatment in the AIDS Clinical Trials Group A5208/OCTANE study in Africa.